CRII: III: Computational framework for disparate data integration to study cancer drug resistance
CRII: III: Computational framework for disparate data integration to study cancer drug resistance
批准号:
1850360
负责人:
Sha Cao
金额:
$17.47万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-15 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
With the advent of high-throughput biotechnology, people can now investigate a biological system with multiple bioassays using diverse types of study objects. The convolution of multiple bioassays, study objects and exposure conditions produces a wealth of rich information about the biological system, and at the same time, poses great challenge on how to integrate heterogeneous data sources and extract sufficient knowledge that cannot be gained from any single dataset alone. Depending on the complexity level of the convolution, direct data integration is often used when combing information from multiple bioassays on a cohort of similar study objects, and indirect integration via knowledge transfer is generally attractive when it comes to the power of incorporating relatively more diverse data types. Direct information integration relies on concordant and well annotated data structures, and the connections between datasets are usually easily understood. These methodologies have to meet many computational challenges owing to different sizes, formats and dimensionalities of the data being integrated. In biological studies, researchers tend to study their system using models varying in terms of species (human vs. mouse), compositions (tissue vs. cell lines, single cells) and/or exposures conditions. Thus, the datasets generated are drawn from different feature space and/or different sample distributions, where direct integration becomes infeasible. These highly disparate datasets may each have the potential to provide complimentary information key to the research question being carried out, and thus it is also urgent to construct a transfer learning method tailored for high-throughput bioassay data so that existing heterogeneous datasets could be re-purposed in a future study.To address these challenges, this project will develop new classes of computational methods for direct information integration and indirect knowledge transfer, and ultimately leverage structures and relations among various bioassay datasets for better understanding of a biological system, for example, cancer drug resistance mechanism. The research team will achieve their goals through exerting the following two objectives. First, they will develop a novel formulation for information distillation on multiple -omics data so that knowledge could be easily transplantable to future studies, which would otherwise be prevented due to technical and platform bias. The framework consists of a supervised sparse clustering method for qualitative representation of coherent signatures, together with a co-clustering approach to detect local low rank structures. Second, they will develop a novel transfer learning method by imposing the structural regularities learnt from the source domains to any target domain. The key assumption is that the structural regularities are invariant to technical and platform bias, so they are ideal vehicle for knowledge transfer. The project is expected to develop novel computational tools that can effectively explore a wide range of heterogeneous datasets, and it has great potential to minimize the cost on recollecting new training data, by maximizing utilization of existing information and fully using the knowledge derived therefrom to substantiate our understanding of a biological/biomedical system. Hence the project will have far-reaching economic and societal impacts.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1109/bibm49941.2020.9313483
发表时间:
2020-12
期刊:
2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
影响因子:
--
作者:
[Changlin Wan;D. Jia;Yue Zhao;Wennan Chang;Sha Cao;Xiao Wang;Chi Zhang]
通讯作者:
Changlin Wan;D. Jia;Yue Zhao;Wennan Chang;Sha Cao;Xiao Wang;Chi Zhang
DOI:
--
发表时间:
2022-08
期刊:
Proceedings of machine learning research
影响因子:
--
作者:
[Changlin Wan;Pengtao Dang;Tong Zhao;Y. Zang;Chi Zhang-;Sha Cao]
通讯作者:
Changlin Wan;Pengtao Dang;Tong Zhao;Y. Zang;Chi Zhang-;Sha Cao
DOI:
--
发表时间:
2020-07
期刊:
ArXiv
影响因子:
--
作者:
[Changlin Wan;Wennan Chang;Tong Zhao;Sha Cao;Chi Zhang]
通讯作者:
Changlin Wan;Wennan Chang;Tong Zhao;Sha Cao;Chi Zhang
Response to ‘Letter to the Editor: on the stability and internal consistency of component-wise sparse mixture regression based clustering’, Zhang et al.
回应“致编辑的信:关于基于组件的稀疏混合回归聚类的稳定性和内部一致性”,Zhang 等人。
DOI:
10.1093/bib/bbac262
发表时间:
2022
期刊:
Briefings in Bioinformatics
影响因子:
9.5
作者:
[Chang, Wennan, Zhang, Chi, Cao, Sha]
通讯作者:
Cao, Sha
DOI:
10.1109/icdm51629.2021.00013
发表时间:
2021-09
期刊:
2021 IEEE International Conference on Data Mining (ICDM)
影响因子:
--
作者:
[Wennan Chang;Pengtao Dang;Changlin Wan;Xiaoyu Lu;Yue Fang;Tong Zhao;Y. Zang;Bo Li;Chi Zhang;Sha Cao]
通讯作者:
Wennan Chang;Pengtao Dang;Changlin Wan;Xiaoyu Lu;Yue Fang;Tong Zhao;Y. Zang;Bo Li;Chi Zhang;Sha Cao
共 8 条
CAREER: Disentangled learning of high dimensional biomedical data in the presence of inherent heterogeneity
-
批准号:2145314
-
项目类别:Standard Grant
-
资助金额:$59.65万
-
财政年份:2022
-
负责人:Sha Cao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于人工智能与多组学的III期结核性脓胸CT“低密度线”形成机制及手术时机预测模型研究
-
批准号:JCZRMS202602483
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于MOF–CRISPR微流控平台的雄黄As(III)/As(V)价态识别与炮制耦合机制研究
-
批准号:JCZRLH202600780
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白术内酯III靶向IRF4-CD36轴通过调控脂质代谢重编程提升结直肠癌奥沙利铂敏感性的机制研究
-
批准号:2026JJ82690
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张卓
-
依托单位:
基于废水零排放的FeS-As(III)置换法从污酸中清洁脱砷处理技术研究
-
批准号:2026JJ30130
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张二军
-
依托单位:
全钒液流电池负极V(II)/V(III)电化学氧化还原的催化机理研究
-
批准号:2025JJ50094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王珏
-
依托单位:
猪纤维蛋白粘合剂预防胸外科术后漏气的适应症拓展研究:一项多中心、随机对照III期临床试验
-
批准号:25SF1901800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵德平
-
依托单位:
HOXC8/OPN/CD44/EGFR轴介导的奥沙利铂耐药性在III期右半结肠癌耐药进展中的研究
-
批准号:2025JJ50694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:喻南慧
-
依托单位:
MXene/nZVI@FH材料微域层界面调控水中砷(III)氧化迁移机制
-
批准号:2025JJ50319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈润华
-
依托单位:
硅基III-V族亚微米线激光器的光场模式调控与耦合机理研究
-
批准号:JCZRQN202501004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
吡咯烷生物碱所致肝窦阻塞综合征III区肝损伤的新机制——局部氨代谢紊乱
-
批准号:JCZRYB202500652
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: